The Immunological Study Lab (ISL) is a DAKKS-accredited laboratory that is compatible with EMA/FDA standards. The laboratory carries out immunological tests to analyze patient samples from clinical trials, performs validation studies for immunological test systems, and offers advice on selecting appropriate immunological biomarkers for monitoring clinical trials.
Because of the lab’s close link to the scientific environment of the research groups at both the Institute for Medical Immunology and the BCRT, newly discovered biomarkers can be quickly transferred to validated test systems. Our proximity to and long-standing close collaboration with the Charité Research Organization (CRO) means that delicate blood samples from clinical studies can be evaluated with sensitive pre-analytics, and abnormal, clinically relevant findings can be communicated in a direct and speedy manner. ISL was and still is involved in contract research collaborations with numerous pharmaceutical and biotechnology companies, including, among others, Baxter, Bayer, Novo Nordisk, Boehringer Ingelheim, Sanofi, Novartis, Biogen, Pluristem and Apceth.